Breaking News Instant updates and real-time market news.

AIG

AIG

$62.32

0.5 (0.81%)

, YUM

Yum! Brands

$69.59

0.37 (0.53%)

09:45
05/16/17
05/16
09:45
05/16/17
09:45

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AIG (AIG) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Kai Pan citing the "strong" new Chief Executive Officer and attractive valuation. 2. Yum! Brands (YUM) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's decision to refranchise an additional 5% of its stores and institute additional cost cutting measures as reasons for the upgrade. 3. Dr Pepper Snapple (DPS) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Dara Mohsenian saying the company's organic sales growth is accelerating driven by an improved competitive outlook as Coca Cola (KO) and Pepsi (PEP) focus on using cash flow from the U.S. carbonated soft drink segment in high growth areas. 4. Regal Entertainment (RGC) upgraded to Buy from Hold at Loop Capital with analyst David Millerciting recent weakness in shares and has confidence the company will pay a special dividend to shareholders around the fourth quarter or in the first half of 2018. 5. Vipshop (VIPS) upgraded to Overweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

AIG

AIG

$62.32

0.5 (0.81%)

YUM

Yum! Brands

$69.59

0.37 (0.53%)

DPS

Dr Pepper Snapple

$92.53

1.44 (1.58%)

RGC

Regal Entertainment

$20.94

0.2 (0.96%)

VIPS

Vipshop

$15.00

0.22 (1.49%)

  • 16

    May

  • 19

    May

  • 31

    May

  • 28

    Jun

AIG AIG
$62.32

0.5 (0.81%)

03/13/17
03/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Morgan Stanley analyst Rajeev Lalwani downgraded Boeing (BA) to Equal Weight from Overweight saying the risk/reward is more balanced with the stock up 40% since mid-2016. Lalwani has a $190 price target for Boeing shares. The analyst this morning coupled the downgrade of Boeing with an upgrade of Rockwell Collins (COL) to Overweight. 2. Deutsche Bank analyst Joshua Shanker downgraded AIG (AIG) to Sell from Hold, saying the resignation of CEO Peter Hancock is a "negative catalyst." The lack of a known successor indicates indecision from the board regarding strategic direction, said Shanker, who cut his price target for the shares to $57 from $61. 3. Goldman Sachs analyst Terence Flynn downgraded Bioverativ (BIVV) to Neutral from Buy citing valuation with the stock near his unchanged price target of $55. 4. RBC Capital downgraded Toronto-Dominion (TD) to Sector Perform from Outperform. Analyst Darko Mihelic says that "damaging reports" about the company's sales practices could harm its reputation, earnings, and valuation. 5. GameStop (GME) downgraded to Market Perform from Outperform at Telsey Advisory. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/14/17
UBSW
03/14/17
NO CHANGE
Target $66
UBSW
Neutral
UBS remains cautious on AIG given uncertainties
UBS analyst Brian Meredith said he remains cautious on AIG shares citing the change in CEO and questions surrounding the company's long-term strategy. Meredith sees limited upside for the shares and sees the current sum-of-the-parts valuation as right around his price target. Meredith maintained his Neutral rating and $66 price target on AIG shares.
04/20/17
WELS
04/20/17
NO CHANGE
WELS
AIG stock likely to fall today, says Wells Fargo
Wells Fargo expects AIG's stock to fall today after the company announced yesterday that it would suffer a pre-tax loss of $100M after the U.K. lowered the discount rate applied to lump-sum bodily injury payouts. The firm lowered its Q1 EPs estimate for the company to $1.20 from $1.35, and it expects AIG's stock to drop today. However, Wells thinks that the hiring of a new CEO will be a positive catalyst for the stock, and it thinks the company is looking to have one in place by its annual general meeting, scheduled for June 28. Wells keeps an Outperform rating on the shares.
05/16/17
MSCO
05/16/17
UPGRADE
Target $72
MSCO
Overweight
AIG upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Kai Pan upgraded AIG to Overweight and increased its price target to $72 from $70 due to the "strong" new CEO and attractive valuation. The analyst said new CEO Brian Duperreault is an industry veteran with a strong track record that can drive sustainable and profitable growth.
YUM Yum! Brands
$69.59

0.37 (0.53%)

05/11/17
05/11/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Caterpillar (CAT) upgraded to Buy from Neutral at BofA/Merrill with analyst Ross Gilardi saying monthly retail sales continue to accelerate and views valuation as much more reasonable. Gilardi believes the company could have another big beat and raise in July and could raise the dividend over the summer. 2. Yum! Brands (YUM) upgraded to Neutral from Sell at Goldman Sachs with analyst Karen Holthouse saying her primary bear thesis, or continued weakness in China comps, has largely played out. She's increasingly positive on Taco Bell and sees limited near-term negative catalysts. 3. Symantec (SYMC) upgraded to Overweight from Equal-Weight at First Analysis with analyst Howard Smith saying he views the recent selloff as a buying opportunity and has increased confidence in the company's long-term growth following its fourth quarter results. 4. Snap (SNAP) upgraded to Outperform from Perform at Oppenheimer and to Neutral from Underweight at Cantor. 5. Electronic Arts (EA) upgraded to Buy from Hold at Ascendiant with analyst Edward Woo noting that the company's fourth quarter results beat expectations and he calls its guidance "strong." According to the analyst ,the company is benefiting from "strength in digital, growth in next gen consoles, and cost management." He calls its upcoming games "solid." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/11/17
GSCO
05/11/17
UPGRADE
Target $65
GSCO
Neutral
Yum! Brands upgraded to Neutral from Sell at Goldman Sachs
Goldman Sachs analyst Karen Holthouse upgraded Yum! Brands to Neutral and raised his price target for the shares to $65 from $57. The analyst says her primary bear thesis, or continued weakness in China comps, has largely played out. She's increasingly positive on Taco Bell and sees limited near-term negative catalysts.
05/16/17
ARGS
05/16/17
UPGRADE
ARGS
Buy
Yum! Brands upgraded to Buy from Hold at Argus
05/16/17
ARGS
05/16/17
UPGRADE
ARGS
Buy
Yum! Brands upgraded on refranchising, cost cutting at Argus
As noted earlier, Argus upgraded Yum! to Buy from Hold. Analyst John Staszak cited the company's decision to refranchise an additional 5% of its stores and institute additional cost cutting measures as reasons for the upgrade. He expects the company's 2017 and 2018 EPS to beat expectations. Target $80.
DPS Dr Pepper Snapple
$92.53

1.44 (1.58%)

03/03/17
03/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Expedia (EXPE) upgraded to Neutral from Sell at Citi with analyst Mark May citing greater comfort in the growth of the company's hotel business. The analyst, who noted that recently disclosed room night and bookings growth at HomeAway gives him a more bullish view on its long-term growth, raised his price target on Expedia shares to $130 from $116. 2. Helmerich & Payne (HP) upgraded to Outperform from Market Perform at Bernstein with analyst Colin Davies citing higher U.S. rig demand and valuation. Target to $84 from $86. 3. Dr Pepper Snapple (DPS) upgraded to Buy from Hold at Jefferies with analyst Kevin Grundy saying that its recently-acquired Bai brand is an underappreciated growth platform for the company. He expects Bai to contribute 2-3 points to Dr Pepper's core sales growth over the next 3-5 years and increased his 2017-18 organic sales and EPS forecasts. Grundy increased his price target on Dr Pepper shares to $115 from $98. 4. KeyCorp (KEY) upgraded to Outperform from Hold at Evercore ISI. 5. Southern Company (SO) upgraded to Buy from Hold at Jefferies with analyst Anthony Crowdell saying he thinks the company will be able to deliver on its 5% earnings per share growth target given all the levers available to pull. He also believes investors are pricing in a Kemper scenario that is worse than worst-case and sees the Vogtle nuclear project is less of a concern than is factored in at current levels, Crowdell tells investors. He raised his price target on Southern Company shares to $56 from $50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/23/17
FBCO
03/23/17
NO CHANGE
Target $111
FBCO
Outperform
Dr Pepper Snapple price target raised to $111 from $105 at Credit Suisse
Credit Suisse analyst Laurent Grandet raised his price target for Dr Pepper Snapple to $111 from $105 as he thinks the stock now merits a higher multiple because the company has secured its most promising Allied Brand, which adds incremental growth of 2%-3% and marginally reduces the risk associated with not controlling those brands. The analyst reiterates an Outperform rating on the shares.
04/26/17
STFL
04/26/17
NO CHANGE
STFL
Dr Pepper Snapple shares defended at Stifel
05/16/17
MSCO
05/16/17
UPGRADE
Target $104
MSCO
Overweight
Dr Pepper Snapple upgraded to Overweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian upgraded Dr Pepper Snapple (DPS) to Overweight from Equal Weight and increased its price target to $104 from $103. The analyst said the company's organic sales growth is accelerating driven by an improved competitive outlook as Coca Cola (KO) and Pepsi (PEP) focus on using cash flow from the US carbonated soft drink segment in high growth areas. Mohsenian also said the recent Bai Brands acquisition will add to long-term growth and concerns are overblown. He recommends the pair trade of long Dr Pepper Snapple and short Church & Dwight (CHD), which was downgraded to Underweight, given Dr Pepper's accelerating growth and Church & Dwight's deteriorating fundamentals.
RGC Regal Entertainment
$20.94

0.2 (0.96%)

02/01/17
02/01/17
DOWNGRADE
Target $34

Neutral
IMAX downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst Omar Sheikh downgraded IMAX (IMAX) to Neutral from Outperform as he sees balanced risk/reward at current levels, given the strong movie slate in 2017/18, slowing growth in China, the likely 1-2 year period before payback comes through on investments in new initiatives, and the full current multiple that leaves little margin for safety. The analyst lowered his price target on the shares to $34 from $42. Sheikh also downgraded AMC Entertainment (AMC) and Regal Entertainment (RGC).
02/01/17
02/01/17
DOWNGRADE
Target $13

Underperform
National CineMedia downgraded to Underperform at Credit Suisse
As previously reported, Credit Suisse analyst Omar Sheikh downgraded National CineMedia (NCMI) to Underperform from Outperform as he believes 2017 will be a tough year for cinema advertising, which suggests there could be limited scope for the company's inventory utilization and CPMs to grow. The analyst lowered his price target on the shares to $13 from $21. He also downgraded AMC Entertainment (AMC), Regal Entertainment (RGC) and IMAX (IMAX).
02/01/17
02/01/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Under Armour (UA, UAA) downgraded to Underperform from Buy at Buckingham, to Market Perform from Outperform at FBR Capital, and to Hold from Buy at Evercore ISI. 2. AMC Entertainment (AMC) and IMAX (IMAX) were downgraded to Neutral from Outperform at Credit Suisse, while Regal Entertainment (RGC) was downgraded to Underperform from Neutral. 3. UPS (UPS) downgraded to Market Perform from Outperform at BMO Capital with analyst Fadi Chamoun saying the company's fourth quarter results were "weak," while it lacks positive catalysts in the near-term. 4. Corning (GLW) downgraded to Market Perform from Outperform at Bernstein with analyst Alberto Moel citing valuation. 5. Mobileye (MBLY) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Adam Jonas saying he is positive on ADAS market growth but also sees more rapid commoditization pressuring margins. Jonas expects the pace of growth to be driven by affordability and increased competition, leading to a larger market opportunity, but lower margins and reduced OEM dependency on one dominant technology supplier. Further, the analyst believes Mobileye will need to increase its R&D capacity and internal human resources in order to remain a long-term key player in the industry. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/16/17
LOOP
05/16/17
UPGRADE
Target $25
LOOP
Buy
Regal Entertainment upgraded to Buy from Hold at Loop Capital
Loop Capital analyst David Miller upgraded Regal Entertainment to Buy from Hold and increased its price target to $25 from $23. The analyst recommends taking advantage of recent weakness in shares and has confidence the company will pay a special dividend to shareholders around Q4 or in 1H 2018. The analyst said Regal pays a special dividend on average every two years and has not paid once since December 2014. Miller would not be surprised if the dividend is of the magnitude of a $1.00/share given current cash levels and free cash flow generation.
VIPS Vipshop
$15.00

0.22 (1.49%)

11/10/16
DBAB
11/10/16
UPGRADE
DBAB
Buy
Vipshop upgraded to Buy from Hold at Deutsche Bank
05/16/17
JPMS
05/16/17
UPGRADE
JPMS
Overweight
Vipshop upgraded to Overweight from Neutral at JPMorgan
03/22/17
PACS
03/22/17
INITIATION
Target $17
PACS
Overweight
Vipshop initiated with an Overweight at Pacific Crest
Pacific Crest initiated Vipshop with an Overweight and a $17 price target.
01/11/17
BERN
01/11/17
INITIATION
BERN
Underperform
Vipshop initiated with an Underperform at Bernstein
Bernstein analyst Bhavtosh Vajpayee started coverage of Vipshop with a $10 price target and an Underperform rating.

TODAY'S FREE FLY STORIES

DNKN

Dunkin' Brands

$58.32

0.15 (0.26%)

07:32
05/31/17
05/31
07:32
05/31/17
07:32
Hot Stocks
Dunkin' Brands names Kate Jaspon as CFO, effective June 5 »

Dunkin' Brands Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

, UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Recommendations
Exact Sciences, UnitedHealth analyst commentary  »

Exact Sciences remains a…

EXAS

Exact Sciences

$32.65

-0.67 (-2.01%)

UNH

UnitedHealth

$176.59

-0.91 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 31

    May

  • 06

    Jun

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

, NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Hot Stocks
Qualcomm extends cash tender offer for NXP Semiconductors outstanding shares »

Qualcomm (QCOM) announced…

QCOM

Qualcomm

$57.34

-0.18 (-0.31%)

NXPI

NXP Semiconductors

$108.14

0.14 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 09

    Jun

FRO

Frontline

$5.41

-0.22 (-3.91%)

07:31
05/31/17
05/31
07:31
05/31/17
07:31
Upgrade
Frontline rating change  »

Frontline upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EGHT

8x8, Inc.

$13.60

0.1 (0.74%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Conference/Events
8x8, Inc. management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 01

    Jun

  • 06

    Jun

  • 06

    Jun

  • 08

    Jun

  • 13

    Jun

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

, FRO

Frontline

$5.41

-0.22 (-3.91%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Recommendations
Gener8 Maritime, Frontline, DHT Holdings analyst commentary  »

Gener8 Maritime advance…

GNRT

Gener8 Maritime

$4.91

0.06 (1.24%)

FRO

Frontline

$5.41

-0.22 (-3.91%)

DHT

DHT Holdings

$4.20

-0.07 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

, ORCL

Oracle

$45.42

0.16 (0.35%)

07:30
05/31/17
05/31
07:30
05/31/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

WLL

Whiting Petroleum

$7.28

-0.69 (-8.66%)

ORCL

Oracle

$45.42

0.16 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:25
05/31/17
05/31
07:25
05/31/17
07:25
Technical Analysis
Technical View: Michael Kors drops to new 52-week low after earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

CBS

CBS

$61.52

-0.05 (-0.08%)

, CBS.A

$63.50

-0.15 (-0.24%)

07:24
05/31/17
05/31
07:24
05/31/17
07:24
Periodicals
Scott Pelley to depart anchor role on 'CBS Evening News,' NY Times says »

CBS (CBS, CBS.A) news…

CBS

CBS

$61.52

-0.05 (-0.08%)

CBS.A

$63.50

-0.15 (-0.24%)

CMCSA

Comcast

$41.10

0.19 (0.46%)

CMCSK

Comcast

DIS

Disney

$108.34

-0.07 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

  • 08

    Jun

  • 15

    Jun

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Hot Stocks
Breaking Hot Stocks news story on Michael Kors »

Michael Kors drops 7% in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

UAA

Under Armour

$19.56

-0.13 (-0.66%)

07:23
05/31/17
05/31
07:23
05/31/17
07:23
Recommendations
Under Armour analyst commentary  »

Under Armour has reached…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

07:22
05/31/17
05/31
07:22
05/31/17
07:22
General news
Futures higher ahead of final trading for May »

Stock futures are above…

KORS

Michael Kors

$36.27

-0.49 (-1.33%)

07:22
05/31/17
05/31
07:22
05/31/17
07:22
Hot Stocks
Michael Kors says to close 100-125 full-price retail stores over next two years »

Michael Kors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

MYL

Mylan

$39.36

-0.36 (-0.91%)

07:19
05/31/17
05/31
07:19
05/31/17
07:19
Recommendations
Mylan analyst commentary  »

Pension fund campaign a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

  • 09

    Oct

VIAB

Viacom

$35.05

-0.08 (-0.23%)

, VIA

Viacom

$38.90

0.5 (1.30%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Recommendations
Viacom, Viacom analyst commentary  »

Viacom price target…

VIAB

Viacom

$35.05

-0.08 (-0.23%)

VIA

Viacom

$38.90

0.5 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$1.37

-0.02 (-1.44%)

07:17
05/31/17
05/31
07:17
05/31/17
07:17
Hot Stocks
22nd Century reports 'dramatic surge' in VLN tobacco clinical trials, science »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$45.00

0.29 (0.65%)

07:16
05/31/17
05/31
07:16
05/31/17
07:16
Recommendations
Abbott analyst commentary  »

Abbott making progress, …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRMN

Garmin

$52.11

-0.29 (-0.55%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Hot Stocks
Garmin launches Approach S60 golf watch »

Garmin International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLCA

U.S. Silica

$36.45

-0.76 (-2.04%)

07:15
05/31/17
05/31
07:15
05/31/17
07:15
Technical Analysis
Technical View: U.S. Silica trades higher in pre-market »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

GPRK

GeoPark

$8.71

-0.18 (-2.02%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
GeoPark names Coulter Enterprises Chairman and CEO Coulter to board »

GeoPark Limited announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRQR

ProQR Therapeutics

$4.70

-0.3 (-6.00%)

07:12
05/31/17
05/31
07:12
05/31/17
07:12
Hot Stocks
ProQR Therapeutics' QR-110 granted Fast Track designation by FDA »

ProQR Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOH

Molina Healthcare

$66.30

-0.57 (-0.85%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Downgrade
Molina Healthcare rating change  »

Molina Healthcare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSK

GlaxoSmithKline

$43.41

0.74 (1.73%)

07:11
05/31/17
05/31
07:11
05/31/17
07:11
Technical Analysis
Technical View: GlaxoSmithKline rises in early trading »

Shares were last up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

RGNX

Regenxbio

$16.70

-1.3 (-7.22%)

07:09
05/31/17
05/31
07:09
05/31/17
07:09
Earnings
Regenxbio initiates Phase 1 clinical trial of RGX-314 for macular degeneration »

Regenxbio has dosed the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$130.49

-3.89 (-2.89%)

07:08
05/31/17
05/31
07:08
05/31/17
07:08
Recommendations
Incyte analyst commentary  »

Incyte price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Jun

  • 13

    Jun

  • 15

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.